 | • レポートコード：MRC308GR09518 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のCD31抗体の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のCD31抗体市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– CD31抗体の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
CD31抗体市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・モノクローナル、ポリクローナル
用途別セグメント
・免疫化学（IHC）、免疫蛍光（IF）、ウェスタンブロット（WB）、免疫細胞化学（ICC）、ELISA、その他
主要な市場プレーヤー
・BosterBio、Bio-Rad、Bioss、Thermo Fisher Scientific、NSJ Bioreagents、R and D Systems、Abcam、BioLegend、GeneTex、Novus Biologicals、SouthernBiotech、LifeSpan BioSciences、Enzo Life Sciences、Bethyl Laboratories、Abbexa、ProSci、Proteintech、Synaptic Systems、BIOCARE MEDICAL、CUSABIO Technology、Absolute Antibody、EpiGentek、Biorbyt、Wuhan Fine Biotech、Sino Biological
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、CD31抗体製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なCD31抗体メーカーの企業概要、2019年～2022年までのCD31抗体の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なCD31抗体メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別CD31抗体の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのCD31抗体の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのCD31抗体市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびCD31抗体の産業チェーンを掲載しています。
・第14、15章では、CD31抗体の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– CD31抗体の概要
– 種類別分析（2018年vs2022年vs2029年）：モノクローナル、ポリクローナル
– 用途別分析（2018年vs2022年vs2029年）：免疫化学（IHC）、免疫蛍光（IF）、ウェスタンブロット（WB）、免疫細胞化学（ICC）、ELISA、その他
– 世界のCD31抗体市場規模・予測
– 世界のCD31抗体生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– BosterBio、Bio-Rad、Bioss、Thermo Fisher Scientific、NSJ Bioreagents、R and D Systems、Abcam、BioLegend、GeneTex、Novus Biologicals、SouthernBiotech、LifeSpan BioSciences、Enzo Life Sciences、Bethyl Laboratories、Abbexa、ProSci、Proteintech、Synaptic Systems、BIOCARE MEDICAL、CUSABIO Technology、Absolute Antibody、EpiGentek、Biorbyt、Wuhan Fine Biotech、Sino Biological
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：モノクローナル、ポリクローナル
・用途別分析2018年-2029年：免疫化学（IHC）、免疫蛍光（IF）、ウェスタンブロット（WB）、免疫細胞化学（ICC）、ELISA、その他
・CD31抗体の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・CD31抗体のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・CD31抗体のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・CD31抗体の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・CD31抗体の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of CD31 Antibody
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global CD31 Antibody Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Monoclonal
1.3.3 Polyclonal
1.4 Market Analysis by Application
1.4.1 Overview: Global CD31 Antibody Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Immunochemistry (IHC)
1.4.3 Immunofluorescence (IF)
1.4.4 Western Blot (WB)
1.4.5 Immunocytochemistry (ICC)
1.4.6 ELISA
1.4.7 Others
1.5 Global CD31 Antibody Market Size & Forecast
1.5.1 Global CD31 Antibody Consumption Value (2018 & 2022 & 2029)
1.5.2 Global CD31 Antibody Sales Quantity (2018-2029)
1.5.3 Global CD31 Antibody Average Price (2018-2029)
2 Manufacturers Profiles
2.1 BosterBio
2.1.1 BosterBio Details
2.1.2 BosterBio Major Business
2.1.3 BosterBio CD31 Antibody Product and Services
2.1.4 BosterBio CD31 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 BosterBio Recent Developments/Updates
2.2 Bio-Rad
2.2.1 Bio-Rad Details
2.2.2 Bio-Rad Major Business
2.2.3 Bio-Rad CD31 Antibody Product and Services
2.2.4 Bio-Rad CD31 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bio-Rad Recent Developments/Updates
2.3 Bioss
2.3.1 Bioss Details
2.3.2 Bioss Major Business
2.3.3 Bioss CD31 Antibody Product and Services
2.3.4 Bioss CD31 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bioss Recent Developments/Updates
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific CD31 Antibody Product and Services
2.4.4 Thermo Fisher Scientific CD31 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Thermo Fisher Scientific Recent Developments/Updates
2.5 NSJ Bioreagents
2.5.1 NSJ Bioreagents Details
2.5.2 NSJ Bioreagents Major Business
2.5.3 NSJ Bioreagents CD31 Antibody Product and Services
2.5.4 NSJ Bioreagents CD31 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 NSJ Bioreagents Recent Developments/Updates
2.6 R and D Systems
2.6.1 R and D Systems Details
2.6.2 R and D Systems Major Business
2.6.3 R and D Systems CD31 Antibody Product and Services
2.6.4 R and D Systems CD31 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 R and D Systems Recent Developments/Updates
2.7 Abcam
2.7.1 Abcam Details
2.7.2 Abcam Major Business
2.7.3 Abcam CD31 Antibody Product and Services
2.7.4 Abcam CD31 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Abcam Recent Developments/Updates
2.8 BioLegend
2.8.1 BioLegend Details
2.8.2 BioLegend Major Business
2.8.3 BioLegend CD31 Antibody Product and Services
2.8.4 BioLegend CD31 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 BioLegend Recent Developments/Updates
2.9 GeneTex
2.9.1 GeneTex Details
2.9.2 GeneTex Major Business
2.9.3 GeneTex CD31 Antibody Product and Services
2.9.4 GeneTex CD31 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 GeneTex Recent Developments/Updates
2.10 Novus Biologicals
2.10.1 Novus Biologicals Details
2.10.2 Novus Biologicals Major Business
2.10.3 Novus Biologicals CD31 Antibody Product and Services
2.10.4 Novus Biologicals CD31 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Novus Biologicals Recent Developments/Updates
2.11 SouthernBiotech
2.11.1 SouthernBiotech Details
2.11.2 SouthernBiotech Major Business
2.11.3 SouthernBiotech CD31 Antibody Product and Services
2.11.4 SouthernBiotech CD31 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 SouthernBiotech Recent Developments/Updates
2.12 LifeSpan BioSciences
2.12.1 LifeSpan BioSciences Details
2.12.2 LifeSpan BioSciences Major Business
2.12.3 LifeSpan BioSciences CD31 Antibody Product and Services
2.12.4 LifeSpan BioSciences CD31 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 LifeSpan BioSciences Recent Developments/Updates
2.13 Enzo Life Sciences
2.13.1 Enzo Life Sciences Details
2.13.2 Enzo Life Sciences Major Business
2.13.3 Enzo Life Sciences CD31 Antibody Product and Services
2.13.4 Enzo Life Sciences CD31 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Enzo Life Sciences Recent Developments/Updates
2.14 Bethyl Laboratories
2.14.1 Bethyl Laboratories Details
2.14.2 Bethyl Laboratories Major Business
2.14.3 Bethyl Laboratories CD31 Antibody Product and Services
2.14.4 Bethyl Laboratories CD31 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Bethyl Laboratories Recent Developments/Updates
2.15 Abbexa
2.15.1 Abbexa Details
2.15.2 Abbexa Major Business
2.15.3 Abbexa CD31 Antibody Product and Services
2.15.4 Abbexa CD31 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Abbexa Recent Developments/Updates
2.16 ProSci
2.16.1 ProSci Details
2.16.2 ProSci Major Business
2.16.3 ProSci CD31 Antibody Product and Services
2.16.4 ProSci CD31 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 ProSci Recent Developments/Updates
2.17 Proteintech
2.17.1 Proteintech Details
2.17.2 Proteintech Major Business
2.17.3 Proteintech CD31 Antibody Product and Services
2.17.4 Proteintech CD31 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Proteintech Recent Developments/Updates
2.18 Synaptic Systems
2.18.1 Synaptic Systems Details
2.18.2 Synaptic Systems Major Business
2.18.3 Synaptic Systems CD31 Antibody Product and Services
2.18.4 Synaptic Systems CD31 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Synaptic Systems Recent Developments/Updates
2.19 BIOCARE MEDICAL
2.19.1 BIOCARE MEDICAL Details
2.19.2 BIOCARE MEDICAL Major Business
2.19.3 BIOCARE MEDICAL CD31 Antibody Product and Services
2.19.4 BIOCARE MEDICAL CD31 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 BIOCARE MEDICAL Recent Developments/Updates
2.20 CUSABIO Technology
2.20.1 CUSABIO Technology Details
2.20.2 CUSABIO Technology Major Business
2.20.3 CUSABIO Technology CD31 Antibody Product and Services
2.20.4 CUSABIO Technology CD31 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 CUSABIO Technology Recent Developments/Updates
2.21 Absolute Antibody
2.21.1 Absolute Antibody Details
2.21.2 Absolute Antibody Major Business
2.21.3 Absolute Antibody CD31 Antibody Product and Services
2.21.4 Absolute Antibody CD31 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Absolute Antibody Recent Developments/Updates
2.22 EpiGentek
2.22.1 EpiGentek Details
2.22.2 EpiGentek Major Business
2.22.3 EpiGentek CD31 Antibody Product and Services
2.22.4 EpiGentek CD31 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 EpiGentek Recent Developments/Updates
2.23 Biorbyt
2.23.1 Biorbyt Details
2.23.2 Biorbyt Major Business
2.23.3 Biorbyt CD31 Antibody Product and Services
2.23.4 Biorbyt CD31 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 Biorbyt Recent Developments/Updates
2.24 Wuhan Fine Biotech
2.24.1 Wuhan Fine Biotech Details
2.24.2 Wuhan Fine Biotech Major Business
2.24.3 Wuhan Fine Biotech CD31 Antibody Product and Services
2.24.4 Wuhan Fine Biotech CD31 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.24.5 Wuhan Fine Biotech Recent Developments/Updates
2.25 Sino Biological
2.25.1 Sino Biological Details
2.25.2 Sino Biological Major Business
2.25.3 Sino Biological CD31 Antibody Product and Services
2.25.4 Sino Biological CD31 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.25.5 Sino Biological Recent Developments/Updates
3 Competitive Environment: CD31 Antibody by Manufacturer
3.1 Global CD31 Antibody Sales Quantity by Manufacturer (2018-2023)
3.2 Global CD31 Antibody Revenue by Manufacturer (2018-2023)
3.3 Global CD31 Antibody Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of CD31 Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 CD31 Antibody Manufacturer Market Share in 2022
3.4.2 Top 6 CD31 Antibody Manufacturer Market Share in 2022
3.5 CD31 Antibody Market: Overall Company Footprint Analysis
3.5.1 CD31 Antibody Market: Region Footprint
3.5.2 CD31 Antibody Market: Company Product Type Footprint
3.5.3 CD31 Antibody Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global CD31 Antibody Market Size by Region
4.1.1 Global CD31 Antibody Sales Quantity by Region (2018-2029)
4.1.2 Global CD31 Antibody Consumption Value by Region (2018-2029)
4.1.3 Global CD31 Antibody Average Price by Region (2018-2029)
4.2 North America CD31 Antibody Consumption Value (2018-2029)
4.3 Europe CD31 Antibody Consumption Value (2018-2029)
4.4 Asia-Pacific CD31 Antibody Consumption Value (2018-2029)
4.5 South America CD31 Antibody Consumption Value (2018-2029)
4.6 Middle East and Africa CD31 Antibody Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global CD31 Antibody Sales Quantity by Type (2018-2029)
5.2 Global CD31 Antibody Consumption Value by Type (2018-2029)
5.3 Global CD31 Antibody Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global CD31 Antibody Sales Quantity by Application (2018-2029)
6.2 Global CD31 Antibody Consumption Value by Application (2018-2029)
6.3 Global CD31 Antibody Average Price by Application (2018-2029)
7 North America
7.1 North America CD31 Antibody Sales Quantity by Type (2018-2029)
7.2 North America CD31 Antibody Sales Quantity by Application (2018-2029)
7.3 North America CD31 Antibody Market Size by Country
7.3.1 North America CD31 Antibody Sales Quantity by Country (2018-2029)
7.3.2 North America CD31 Antibody Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe CD31 Antibody Sales Quantity by Type (2018-2029)
8.2 Europe CD31 Antibody Sales Quantity by Application (2018-2029)
8.3 Europe CD31 Antibody Market Size by Country
8.3.1 Europe CD31 Antibody Sales Quantity by Country (2018-2029)
8.3.2 Europe CD31 Antibody Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific CD31 Antibody Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific CD31 Antibody Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific CD31 Antibody Market Size by Region
9.3.1 Asia-Pacific CD31 Antibody Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific CD31 Antibody Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America CD31 Antibody Sales Quantity by Type (2018-2029)
10.2 South America CD31 Antibody Sales Quantity by Application (2018-2029)
10.3 South America CD31 Antibody Market Size by Country
10.3.1 South America CD31 Antibody Sales Quantity by Country (2018-2029)
10.3.2 South America CD31 Antibody Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa CD31 Antibody Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa CD31 Antibody Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa CD31 Antibody Market Size by Country
11.3.1 Middle East & Africa CD31 Antibody Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa CD31 Antibody Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 CD31 Antibody Market Drivers
12.2 CD31 Antibody Market Restraints
12.3 CD31 Antibody Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of CD31 Antibody and Key Manufacturers
13.2 Manufacturing Costs Percentage of CD31 Antibody
13.3 CD31 Antibody Production Process
13.4 CD31 Antibody Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 CD31 Antibody Typical Distributors
14.3 CD31 Antibody Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global CD31 Antibody Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global CD31 Antibody Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. BosterBio Basic Information, Manufacturing Base and Competitors
Table 4. BosterBio Major Business
Table 5. BosterBio CD31 Antibody Product and Services
Table 6. BosterBio CD31 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. BosterBio Recent Developments/Updates
Table 8. Bio-Rad Basic Information, Manufacturing Base and Competitors
Table 9. Bio-Rad Major Business
Table 10. Bio-Rad CD31 Antibody Product and Services
Table 11. Bio-Rad CD31 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Bio-Rad Recent Developments/Updates
Table 13. Bioss Basic Information, Manufacturing Base and Competitors
Table 14. Bioss Major Business
Table 15. Bioss CD31 Antibody Product and Services
Table 16. Bioss CD31 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Bioss Recent Developments/Updates
Table 18. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 19. Thermo Fisher Scientific Major Business
Table 20. Thermo Fisher Scientific CD31 Antibody Product and Services
Table 21. Thermo Fisher Scientific CD31 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Thermo Fisher Scientific Recent Developments/Updates
Table 23. NSJ Bioreagents Basic Information, Manufacturing Base and Competitors
Table 24. NSJ Bioreagents Major Business
Table 25. NSJ Bioreagents CD31 Antibody Product and Services
Table 26. NSJ Bioreagents CD31 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. NSJ Bioreagents Recent Developments/Updates
Table 28. R and D Systems Basic Information, Manufacturing Base and Competitors
Table 29. R and D Systems Major Business
Table 30. R and D Systems CD31 Antibody Product and Services
Table 31. R and D Systems CD31 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. R and D Systems Recent Developments/Updates
Table 33. Abcam Basic Information, Manufacturing Base and Competitors
Table 34. Abcam Major Business
Table 35. Abcam CD31 Antibody Product and Services
Table 36. Abcam CD31 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Abcam Recent Developments/Updates
Table 38. BioLegend Basic Information, Manufacturing Base and Competitors
Table 39. BioLegend Major Business
Table 40. BioLegend CD31 Antibody Product and Services
Table 41. BioLegend CD31 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. BioLegend Recent Developments/Updates
Table 43. GeneTex Basic Information, Manufacturing Base and Competitors
Table 44. GeneTex Major Business
Table 45. GeneTex CD31 Antibody Product and Services
Table 46. GeneTex CD31 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. GeneTex Recent Developments/Updates
Table 48. Novus Biologicals Basic Information, Manufacturing Base and Competitors
Table 49. Novus Biologicals Major Business
Table 50. Novus Biologicals CD31 Antibody Product and Services
Table 51. Novus Biologicals CD31 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Novus Biologicals Recent Developments/Updates
Table 53. SouthernBiotech Basic Information, Manufacturing Base and Competitors
Table 54. SouthernBiotech Major Business
Table 55. SouthernBiotech CD31 Antibody Product and Services
Table 56. SouthernBiotech CD31 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. SouthernBiotech Recent Developments/Updates
Table 58. LifeSpan BioSciences Basic Information, Manufacturing Base and Competitors
Table 59. LifeSpan BioSciences Major Business
Table 60. LifeSpan BioSciences CD31 Antibody Product and Services
Table 61. LifeSpan BioSciences CD31 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. LifeSpan BioSciences Recent Developments/Updates
Table 63. Enzo Life Sciences Basic Information, Manufacturing Base and Competitors
Table 64. Enzo Life Sciences Major Business
Table 65. Enzo Life Sciences CD31 Antibody Product and Services
Table 66. Enzo Life Sciences CD31 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Enzo Life Sciences Recent Developments/Updates
Table 68. Bethyl Laboratories Basic Information, Manufacturing Base and Competitors
Table 69. Bethyl Laboratories Major Business
Table 70. Bethyl Laboratories CD31 Antibody Product and Services
Table 71. Bethyl Laboratories CD31 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Bethyl Laboratories Recent Developments/Updates
Table 73. Abbexa Basic Information, Manufacturing Base and Competitors
Table 74. Abbexa Major Business
Table 75. Abbexa CD31 Antibody Product and Services
Table 76. Abbexa CD31 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Abbexa Recent Developments/Updates
Table 78. ProSci Basic Information, Manufacturing Base and Competitors
Table 79. ProSci Major Business
Table 80. ProSci CD31 Antibody Product and Services
Table 81. ProSci CD31 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. ProSci Recent Developments/Updates
Table 83. Proteintech Basic Information, Manufacturing Base and Competitors
Table 84. Proteintech Major Business
Table 85. Proteintech CD31 Antibody Product and Services
Table 86. Proteintech CD31 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Proteintech Recent Developments/Updates
Table 88. Synaptic Systems Basic Information, Manufacturing Base and Competitors
Table 89. Synaptic Systems Major Business
Table 90. Synaptic Systems CD31 Antibody Product and Services
Table 91. Synaptic Systems CD31 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Synaptic Systems Recent Developments/Updates
Table 93. BIOCARE MEDICAL Basic Information, Manufacturing Base and Competitors
Table 94. BIOCARE MEDICAL Major Business
Table 95. BIOCARE MEDICAL CD31 Antibody Product and Services
Table 96. BIOCARE MEDICAL CD31 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. BIOCARE MEDICAL Recent Developments/Updates
Table 98. CUSABIO Technology Basic Information, Manufacturing Base and Competitors
Table 99. CUSABIO Technology Major Business
Table 100. CUSABIO Technology CD31 Antibody Product and Services
Table 101. CUSABIO Technology CD31 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. CUSABIO Technology Recent Developments/Updates
Table 103. Absolute Antibody Basic Information, Manufacturing Base and Competitors
Table 104. Absolute Antibody Major Business
Table 105. Absolute Antibody CD31 Antibody Product and Services
Table 106. Absolute Antibody CD31 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Absolute Antibody Recent Developments/Updates
Table 108. EpiGentek Basic Information, Manufacturing Base and Competitors
Table 109. EpiGentek Major Business
Table 110. EpiGentek CD31 Antibody Product and Services
Table 111. EpiGentek CD31 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 112. EpiGentek Recent Developments/Updates
Table 113. Biorbyt Basic Information, Manufacturing Base and Competitors
Table 114. Biorbyt Major Business
Table 115. Biorbyt CD31 Antibody Product and Services
Table 116. Biorbyt CD31 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 117. Biorbyt Recent Developments/Updates
Table 118. Wuhan Fine Biotech Basic Information, Manufacturing Base and Competitors
Table 119. Wuhan Fine Biotech Major Business
Table 120. Wuhan Fine Biotech CD31 Antibody Product and Services
Table 121. Wuhan Fine Biotech CD31 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 122. Wuhan Fine Biotech Recent Developments/Updates
Table 123. Sino Biological Basic Information, Manufacturing Base and Competitors
Table 124. Sino Biological Major Business
Table 125. Sino Biological CD31 Antibody Product and Services
Table 126. Sino Biological CD31 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 127. Sino Biological Recent Developments/Updates
Table 128. Global CD31 Antibody Sales Quantity by Manufacturer (2018-2023) & (L)
Table 129. Global CD31 Antibody Revenue by Manufacturer (2018-2023) & (USD Million)
Table 130. Global CD31 Antibody Average Price by Manufacturer (2018-2023) & (US$/L)
Table 131. Market Position of Manufacturers in CD31 Antibody, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 132. Head Office and CD31 Antibody Production Site of Key Manufacturer
Table 133. CD31 Antibody Market: Company Product Type Footprint
Table 134. CD31 Antibody Market: Company Product Application Footprint
Table 135. CD31 Antibody New Market Entrants and Barriers to Market Entry
Table 136. CD31 Antibody Mergers, Acquisition, Agreements, and Collaborations
Table 137. Global CD31 Antibody Sales Quantity by Region (2018-2023) & (L)
Table 138. Global CD31 Antibody Sales Quantity by Region (2024-2029) & (L)
Table 139. Global CD31 Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 140. Global CD31 Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 141. Global CD31 Antibody Average Price by Region (2018-2023) & (US$/L)
Table 142. Global CD31 Antibody Average Price by Region (2024-2029) & (US$/L)
Table 143. Global CD31 Antibody Sales Quantity by Type (2018-2023) & (L)
Table 144. Global CD31 Antibody Sales Quantity by Type (2024-2029) & (L)
Table 145. Global CD31 Antibody Consumption Value by Type (2018-2023) & (USD Million)
Table 146. Global CD31 Antibody Consumption Value by Type (2024-2029) & (USD Million)
Table 147. Global CD31 Antibody Average Price by Type (2018-2023) & (US$/L)
Table 148. Global CD31 Antibody Average Price by Type (2024-2029) & (US$/L)
Table 149. Global CD31 Antibody Sales Quantity by Application (2018-2023) & (L)
Table 150. Global CD31 Antibody Sales Quantity by Application (2024-2029) & (L)
Table 151. Global CD31 Antibody Consumption Value by Application (2018-2023) & (USD Million)
Table 152. Global CD31 Antibody Consumption Value by Application (2024-2029) & (USD Million)
Table 153. Global CD31 Antibody Average Price by Application (2018-2023) & (US$/L)
Table 154. Global CD31 Antibody Average Price by Application (2024-2029) & (US$/L)
Table 155. North America CD31 Antibody Sales Quantity by Type (2018-2023) & (L)
Table 156. North America CD31 Antibody Sales Quantity by Type (2024-2029) & (L)
Table 157. North America CD31 Antibody Sales Quantity by Application (2018-2023) & (L)
Table 158. North America CD31 Antibody Sales Quantity by Application (2024-2029) & (L)
Table 159. North America CD31 Antibody Sales Quantity by Country (2018-2023) & (L)
Table 160. North America CD31 Antibody Sales Quantity by Country (2024-2029) & (L)
Table 161. North America CD31 Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 162. North America CD31 Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 163. Europe CD31 Antibody Sales Quantity by Type (2018-2023) & (L)
Table 164. Europe CD31 Antibody Sales Quantity by Type (2024-2029) & (L)
Table 165. Europe CD31 Antibody Sales Quantity by Application (2018-2023) & (L)
Table 166. Europe CD31 Antibody Sales Quantity by Application (2024-2029) & (L)
Table 167. Europe CD31 Antibody Sales Quantity by Country (2018-2023) & (L)
Table 168. Europe CD31 Antibody Sales Quantity by Country (2024-2029) & (L)
Table 169. Europe CD31 Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 170. Europe CD31 Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 171. Asia-Pacific CD31 Antibody Sales Quantity by Type (2018-2023) & (L)
Table 172. Asia-Pacific CD31 Antibody Sales Quantity by Type (2024-2029) & (L)
Table 173. Asia-Pacific CD31 Antibody Sales Quantity by Application (2018-2023) & (L)
Table 174. Asia-Pacific CD31 Antibody Sales Quantity by Application (2024-2029) & (L)
Table 175. Asia-Pacific CD31 Antibody Sales Quantity by Region (2018-2023) & (L)
Table 176. Asia-Pacific CD31 Antibody Sales Quantity by Region (2024-2029) & (L)
Table 177. Asia-Pacific CD31 Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 178. Asia-Pacific CD31 Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 179. South America CD31 Antibody Sales Quantity by Type (2018-2023) & (L)
Table 180. South America CD31 Antibody Sales Quantity by Type (2024-2029) & (L)
Table 181. South America CD31 Antibody Sales Quantity by Application (2018-2023) & (L)
Table 182. South America CD31 Antibody Sales Quantity by Application (2024-2029) & (L)
Table 183. South America CD31 Antibody Sales Quantity by Country (2018-2023) & (L)
Table 184. South America CD31 Antibody Sales Quantity by Country (2024-2029) & (L)
Table 185. South America CD31 Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 186. South America CD31 Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 187. Middle East & Africa CD31 Antibody Sales Quantity by Type (2018-2023) & (L)
Table 188. Middle East & Africa CD31 Antibody Sales Quantity by Type (2024-2029) & (L)
Table 189. Middle East & Africa CD31 Antibody Sales Quantity by Application (2018-2023) & (L)
Table 190. Middle East & Africa CD31 Antibody Sales Quantity by Application (2024-2029) & (L)
Table 191. Middle East & Africa CD31 Antibody Sales Quantity by Region (2018-2023) & (L)
Table 192. Middle East & Africa CD31 Antibody Sales Quantity by Region (2024-2029) & (L)
Table 193. Middle East & Africa CD31 Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 194. Middle East & Africa CD31 Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 195. CD31 Antibody Raw Material
Table 196. Key Manufacturers of CD31 Antibody Raw Materials
Table 197. CD31 Antibody Typical Distributors
Table 198. CD31 Antibody Typical Customers
List of Figures
Figure 1. CD31 Antibody Picture
Figure 2. Global CD31 Antibody Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global CD31 Antibody Consumption Value Market Share by Type in 2022
Figure 4. Monoclonal Examples
Figure 5. Polyclonal Examples
Figure 6. Global CD31 Antibody Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global CD31 Antibody Consumption Value Market Share by Application in 2022
Figure 8. Immunochemistry (IHC) Examples
Figure 9. Immunofluorescence (IF) Examples
Figure 10. Western Blot (WB) Examples
Figure 11. Immunocytochemistry (ICC) Examples
Figure 12. ELISA Examples
Figure 13. Others Examples
Figure 14. Global CD31 Antibody Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global CD31 Antibody Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global CD31 Antibody Sales Quantity (2018-2029) & (L)
Figure 17. Global CD31 Antibody Average Price (2018-2029) & (US$/L)
Figure 18. Global CD31 Antibody Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global CD31 Antibody Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of CD31 Antibody by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 CD31 Antibody Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 CD31 Antibody Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global CD31 Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global CD31 Antibody Consumption Value Market Share by Region (2018-2029)
Figure 25. North America CD31 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe CD31 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific CD31 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 28. South America CD31 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa CD31 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 30. Global CD31 Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global CD31 Antibody Consumption Value Market Share by Type (2018-2029)
Figure 32. Global CD31 Antibody Average Price by Type (2018-2029) & (US$/L)
Figure 33. Global CD31 Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global CD31 Antibody Consumption Value Market Share by Application (2018-2029)
Figure 35. Global CD31 Antibody Average Price by Application (2018-2029) & (US$/L)
Figure 36. North America CD31 Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America CD31 Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America CD31 Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America CD31 Antibody Consumption Value Market Share by Country (2018-2029)
Figure 40. United States CD31 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada CD31 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico CD31 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe CD31 Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe CD31 Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe CD31 Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe CD31 Antibody Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany CD31 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France CD31 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom CD31 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia CD31 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy CD31 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific CD31 Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific CD31 Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific CD31 Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific CD31 Antibody Consumption Value Market Share by Region (2018-2029)
Figure 56. China CD31 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan CD31 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea CD31 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India CD31 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia CD31 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia CD31 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America CD31 Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America CD31 Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America CD31 Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America CD31 Antibody Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil CD31 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina CD31 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa CD31 Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa CD31 Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa CD31 Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa CD31 Antibody Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey CD31 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt CD31 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia CD31 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa CD31 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. CD31 Antibody Market Drivers
Figure 77. CD31 Antibody Market Restraints
Figure 78. CD31 Antibody Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of CD31 Antibody in 2022
Figure 81. Manufacturing Process Analysis of CD31 Antibody
Figure 82. CD31 Antibody Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source